Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends Hemophilia pact
150.12BUSD
taip
Common Stock
Pertukaran
NYSE
Kod matawang
USD
Nama Mata Wang
US Dollar
Nama negara
USA
ISO negara
US
ADALAH DALAM
US7170811035
CUSIP
717081103
Sektor
Healthcare
industri
Drug Manufacturers - General
Akhir Tahun Fiskal
December
tarikh IPO
-
Dikemaskini Pada
-
Nisbah PE
35.07
Nisbah PEG
0.20
Nilai buku
16.29
Bahagian Dividen
1.67
Hasil Dividen
6.54%
Bahagian Pendapatan
0.75
Harga Sasaran Wall Street
31.175
Anggaran EPS Tahun Semasa
2.9271
Anggaran EPS Tahun Depan
2.9256
EPS Anggaran Suku Tahun Semasa
0.62
Anggaran EPS Suku Tahun Seterusnya
0.66
Suku Terkini
-
Hasil TTM
59,375,001,600
Keuntungan Kasar TTM
41,430,999,040
EBITDA
18,365,999,104
Margin keuntungan
7.16%
Pulangan Atas Aset TTM
3.31%
Pulangan Atas Ekuiti TTM
4.54%
Hasil Sesaham TTM
10.493
Pertumbuhan Hasil Qtly YOY
31.20%
Eps TTM yang dicairkan
0.75
Pertumbuhan Pendapatan Qtly YOY
-98.20%
PE mengekori
35.07
PE ke hadapan
8
Harga Jualan TTM
2.5102
Buku Harga MRQ
1.615
Hasil Nilai Perusahaan
3
EBITDA Nilai Perusahaan
14
321.00
3.68%134.98
2.16%78.60
-4.67%728.05
-3.96%98.10
-2.60%288.70
-2.06%171.85
-1.08%36.35
-0.87%66.50
-0.61%147.30
-0.32%Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends Hemophilia pact
Pfizer names oncology chief and company veteran Boshoff as chief scientific officer
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales - CNBC
FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease - CNBC